Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia

This publication has 29 references indexed in Scilit:

• Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
  Journal of Lipid Research, 1998
• A brief review paper of the efficacy and safety of atorvastatin in early clinical trials
  Atherosclerosis, 1997
• Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men
  Circulation, 1997
• Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia
  JAMA, 1996
• Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
  The American Journal of Medicine, 1993
• Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• Low-density lipoprotein subclass patterns and risk of myocardial infarction
  JAMA, 1988
• THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM
  Journal of Clinical Investigation, 1955